Hong Kong Pharmaceuticals & Biotech Most Popular Stocks

China Regenerative Medicine International

Market Cap: HK$231.2m

An investment holding company, provides healthcare products and services in Hong Kong and the People’s Republic of China.

Regent Pacific Group

Market Cap: HK$218.9m

An investment holding company, focuses on healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific.

Kontafarma China Holdings

Market Cap: HK$190.0m

An investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediate in Mainland China, Singapore, Taiwan, and internationally.

China Health Group

Market Cap: HK$184.1m

An investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China.

PuraPharm

Market Cap: HK$177.8m

An investment holding company, engages in research, development, production, and sale of concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally.

Biosino Bio-Technology and Science Incorporation

Market Cap: HK$125.9m

Manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China.

Sanai Health Industry Group

Market Cap: HK$62.7m

An investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, and Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.